Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EMBCNASDAQ:IRMDNASDAQ:NYXHNASDAQ:SIBN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMBCEmbecta$10.72+2.0%$12.13$10.27▼$21.48$626.51M1.24462,043 shs796,519 shsIRMDIradimed$51.09-2.3%$52.24$41.69▼$63.29$649.61M0.9142,668 shs27,862 shsNYXHNyxoah$7.74-7.0%$6.95$5.55▼$11.87$263.62M1.5674,237 shs116,429 shsSIBNSI-BONE$18.38-0.2%$15.24$11.70▼$20.05$783.26M0.82374,592 shs273,310 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMBCEmbecta+2.00%-10.82%-4.63%-23.97%-21.00%IRMDIradimed-2.28%-5.23%-3.11%-9.16%+17.34%NYXHNyxoah-6.97%+23.05%+28.36%-25.22%-24.78%SIBNSI-BONE-0.22%-7.12%+33.00%+3.03%+31.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEMBCEmbecta4.3294 of 5 stars3.21.03.30.02.63.33.8IRMDIradimed4.892 of 5 stars3.53.02.54.43.23.31.9NYXHNyxoah2.8387 of 5 stars3.55.00.00.02.60.80.6SIBNSI-BONE3.5554 of 5 stars2.53.00.03.33.02.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEMBCEmbecta 2.33Hold$19.6783.46% UpsideIRMDIradimed 3.00Buy$72.0040.93% UpsideNYXHNyxoah 3.00Buy$14.5087.34% UpsideSIBNSI-BONE 3.00Buy$22.5022.42% UpsideCurrent Analyst Ratings BreakdownLatest NYXH, SIBN, IRMD, and EMBC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/23/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.005/6/2025SIBNSI-BONETruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$20.00 ➝ $22.005/6/2025SIBNSI-BONECantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.005/6/2025SIBNSI-BONENeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$24.00 ➝ $24.004/21/2025NYXHNyxoahStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $14.004/10/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$15.004/9/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold4/8/2025NYXHNyxoahHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.003/26/2025NYXHNyxoahHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$17.00 ➝ $15.003/14/2025NYXHNyxoahStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$16.00 ➝ $15.002/25/2025SIBNSI-BONETruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$18.00 ➝ $22.00(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEMBCEmbecta$1.08B0.58$2.48 per share4.32($13.23) per share-0.81IRMDIradimed$75.15M8.64$1.27 per share40.12$5.66 per share9.03NYXHNyxoah$4.36M60.41N/AN/AN/A∞SIBNSI-BONE$176.60M4.44N/AN/A$4.18 per share4.40Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEMBCEmbecta$78.30M$0.9010.723.490.785.25%-19.22%11.92%8/8/2025 (Estimated)IRMDIradimed$19.23M$1.5534.0625.55N/A26.26%24.12%21.20%8/7/2025 (Estimated)NYXHNyxoah-$46.77M-$2.13N/AN/AN/A-1,043.93%-51.68%-40.11%8/5/2025 (Estimated)SIBNSI-BONE-$43.34M-$0.64N/AN/AN/A-23.82%-22.51%-16.53%8/4/2025 (Estimated)Latest NYXH, SIBN, IRMD, and EMBC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025NYXHNyxoah-$0.49-$0.63-$0.14-$0.63$1.64 million$1.12 million5/9/2025Q2 2025EMBCEmbecta$0.66$0.70+$0.04$0.40$261.77 million$259.00 million5/5/2025Q1 2025SIBNSI-BONE-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 million3/13/2025Q4 2024NYXHNyxoah-$0.46-$0.49-$0.03-$0.49$2.02 million$1.35 million2/24/2025Q4 2024SIBNSI-BONE-$0.16-$0.11+$0.05-$0.11$48.87 million$49.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEMBCEmbecta$0.605.60%N/A66.67%N/AIRMDIradimed$0.681.33%N/A43.87%1 YearsNYXHNyxoahN/AN/AN/AN/AN/ASIBNSI-BONEN/AN/AN/AN/AN/ALatest NYXH, SIBN, IRMD, and EMBC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025EMBCEmbectaquarterly$0.154.51%5/28/20255/28/20256/13/20255/5/2025IRMDIradimedquarterly$0.171.3%5/20/20255/20/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEMBCEmbectaN/A2.241.67IRMDIradimedN/A9.217.82NYXHNyxoah0.215.284.95SIBNSI-BONE0.228.257.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEMBCEmbecta93.83%IRMDIradimed92.34%NYXHNyxoahN/ASIBNSI-BONE98.11%Insider OwnershipCompanyInsider OwnershipEMBCEmbecta0.42%IRMDIradimed36.80%NYXHNyxoah17.11%SIBNSI-BONE4.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEMBCEmbecta1,90058.44 million57.89 millionOptionableIRMDIradimed11012.72 million7.97 millionOptionableNYXHNyxoah11034.06 million28.23 millionNot OptionableSIBNSI-BONE35042.62 million40.30 millionOptionableNYXH, SIBN, IRMD, and EMBC HeadlinesRecent News About These CompaniesSI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Lazard Asset Management LLCMay 23 at 3:58 AM | marketbeat.comNorthern Trust Corp Increases Holdings in SI-BONE, Inc. (NASDAQ:SIBN)May 23 at 3:09 AM | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Acquired by Paradigm Capital Management Inc. NYMay 22 at 8:00 AM | marketbeat.comVirtus Investment Advisers Inc. Acquires Shares of 13,950 SI-BONE, Inc. (NASDAQ:SIBN)May 21 at 7:39 AM | marketbeat.comInsider Selling: SI-BONE, Inc. (NASDAQ:SIBN) CFO Sells 2,424 Shares of StockMay 21 at 7:11 AM | insidertrades.comSilvercrest Asset Management Group LLC Boosts Position in SI-BONE, Inc. (NASDAQ:SIBN)May 19, 2025 | marketbeat.comMercer Global Advisors Inc. ADV Invests $210,000 in SI-BONE, Inc. (NASDAQ:SIBN)May 19, 2025 | marketbeat.comGraham Capital Management L.P. Invests $498,000 in SI-BONE, Inc. (NASDAQ:SIBN)May 18, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) CFO Anshul Maheshwari Sells 4,937 SharesMay 17, 2025 | marketbeat.comInsider Selling: SI-BONE, Inc. (NASDAQ:SIBN) CFO Sells 4,937 Shares of StockMay 16, 2025 | insidertrades.comParkman Healthcare Partners LLC Acquires 31,284 Shares of SI-BONE, Inc. (NASDAQ:SIBN)May 16, 2025 | marketbeat.comDimensional Fund Advisors LP Has $4.97 Million Holdings in SI-BONE, Inc. (NASDAQ:SIBN)May 15, 2025 | marketbeat.comSI-BONE (NASDAQ:SIBN) Sets New 12-Month High - What's Next?May 14, 2025 | marketbeat.com4 Recent Earnings Winners Riding Fresh Momentum in May (SIBN)May 14, 2025 | marketbeat.comWhat Makes Si-Bone (SIBN) a Strong Momentum Stock: Buy Now?May 13, 2025 | zacks.comSchonfeld Strategic Advisors LLC Takes $426,000 Position in SI-BONE, Inc. (NASDAQ:SIBN)May 13, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by Granahan Investment Management LLCMay 12, 2025 | marketbeat.comEarnings Update: SI-BONE, Inc. (NASDAQ:SIBN) Just Reported Its First-Quarter Results And Analysts Are Updating Their ForecastsMay 9, 2025 | finance.yahoo.comWall Street Analysts Think Si-Bone (SIBN) Could Surge 41.21%: Read This Before Placing a BetMay 8, 2025 | zacks.comSI-BONE (NASDAQ:SIBN) Shares Gap Up After Strong EarningsMay 8, 2025 | marketbeat.comSI-BONE's (SIBN) "Overweight" Rating Reiterated at Cantor FitzgeraldMay 8, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNYXH, SIBN, IRMD, and EMBC Company DescriptionsEmbecta NASDAQ:EMBC$10.72 +0.21 (+2.00%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$10.89 +0.17 (+1.58%) As of 05/23/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.Iradimed NASDAQ:IRMD$51.09 -1.19 (-2.28%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$51.05 -0.04 (-0.08%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.Nyxoah NASDAQ:NYXH$7.74 -0.58 (-6.97%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$8.18 +0.44 (+5.62%) As of 05/23/2025 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.SI-BONE NASDAQ:SIBN$18.38 -0.04 (-0.22%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$18.38 0.00 (-0.03%) As of 05/23/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
